Functional Shots Surge, Graza Explores Sale, Surgery Gets Scrutinized

September 29, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

Functional shots emerge as the next supplement ritual, with the category projected to grow from $6.6B to $19B by 2033 as investors back brands like Sol-ti and Suja The Economist questions the evidence behind common surgeries, finding roughly two-thirds of patient improvement in trials came from natural healing or placebo effects Olive oil brand Graza explores a sale valued between $450M and $600M as larger food companies acquire brands reinventing familiar categories